These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. A new animal model for Epstein-Barr virus pathogenesis. Wang F Curr Top Microbiol Immunol; 2001; 258():201-19. PubMed ID: 11443863 [No Abstract] [Full Text] [Related]
4. Epstein-Barr virus and the B cell: that's all it takes. Thorley-Lawson DA; Miyashita EM; Khan G Trends Microbiol; 1996 May; 4(5):204-8. PubMed ID: 8727601 [TBL] [Abstract][Full Text] [Related]
5. EBV and malignant lymphoma with special emphasis on pyothorax-associated lymphoma. Aozasa K; Kanno H; Miwa H; Tomita Y Curr Top Microbiol Immunol; 2001; 258():103-20. PubMed ID: 11443856 [No Abstract] [Full Text] [Related]
6. The polymorphic element of the Epstein-Barr virus EBNA-3C gene: a preliminary characteristic and the use for distinguishing between mono- and polyclonal infected cells. Myandina GI; Imamova LR; Ostrovskaya AV; Samochatova EV; Itkes AV Dokl Biochem; 2000; 371(1-6):53-6. PubMed ID: 10853450 [No Abstract] [Full Text] [Related]
13. Adoptive immunotherapy for Epstein-Barr virus-related lymphoma. Smith CA; Ng CY; Loftin SK; Li C; Heslop HE; Brenner MK; Rooney CM Leuk Lymphoma; 1996 Oct; 23(3-4):213-20. PubMed ID: 9031101 [TBL] [Abstract][Full Text] [Related]
14. T cells or active Epstein-Barr virus infection in the development of lymphoproliferative disease in human B cell-injected severe combined immunodeficient mice. Coles RE; Boyle TJ; DiMaio JM; Berend KR; Via DF; Lyerly HK Ann Surg Oncol; 1994 Sep; 1(5):405-10. PubMed ID: 7531601 [TBL] [Abstract][Full Text] [Related]
15. A new form of Epstein-Barr virus latency in vivo. Miyashita E; Thorley-Lawson DA Curr Top Microbiol Immunol; 1995; 194():135-44. PubMed ID: 7895488 [No Abstract] [Full Text] [Related]
16. Epstein-Barr virus as an agent of haematological disease. Tosato G; Taga K; Angiolillo AL; Sgadari C Baillieres Clin Haematol; 1995 Mar; 8(1):165-99. PubMed ID: 7663046 [TBL] [Abstract][Full Text] [Related]
17. T-cell memory: lessons from Epstein-Barr virus infection in man. Rickinson AB; Callan MF; Annels NE Philos Trans R Soc Lond B Biol Sci; 2000 Mar; 355(1395):391-400. PubMed ID: 10794060 [TBL] [Abstract][Full Text] [Related]
18. Epstein-Barr virus immortalization and latency. Rowe DT Front Biosci; 1999 Mar; 4():D346-71. PubMed ID: 10077545 [TBL] [Abstract][Full Text] [Related]
19. Malignant lymphoma induction of rabbits with oral spray of Epstein-Barr virus-related herpesvirus from Si-IIA cells (HTLV-II-transformed Cynomolgus cell line): a possible animal model for Epstein-Barr virus infection and subsequent virus-related tumors in humans. Koirala TR; Hayashi K; Chen HL; Ino H; Kariya N; Yanai H; Choudhury CR; Akagi T Pathol Int; 1997 Jul; 47(7):442-8. PubMed ID: 9234382 [TBL] [Abstract][Full Text] [Related]
20. Inhibition of ubiquitin/proteasome-dependent protein degradation by the Gly-Ala repeat domain of the Epstein-Barr virus nuclear antigen 1. Levitskaya J; Sharipo A; Leonchiks A; Ciechanover A; Masucci MG Proc Natl Acad Sci U S A; 1997 Nov; 94(23):12616-21. PubMed ID: 9356498 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]